Interfacing news reporter tang jiayan
Interface news editor, xie xin
In recent days, a number of doctors and pharmacists have indicated in the social media that the cost of hospital first aid has recently increased: “the earth can't afford it”, and suddenly the price of commonly used drugs, such as rice and urine, has increased by about 10 times. The drugs covered by the increase in price included, inter alia, first aid drugs, such as westland, which is frequently used in the emergency room, and semison injection fluids for acetic anhydride。
On 14 april, interface journalists confirmed to a number of pharmacists that this was indeed the case. “it is true that, on this side of the emergency, this drug was almost unusable and cheap, but that the lack of supplies led to a price hike.” according to a ill-intentioned pharmacist。
According to the cullen gardensinight database, the prices of all first aid medicines increased to varying degrees from the average purchase price between 2008 and 2020. Among them, the acetic acid semesone injection for immunitis increased from 0. 12 to 230, more than 200 times. The second was an increase in the price of westland from $2. 6 to $83. 81, 40 times the price, and an increase in the price of the antidote chlorophosphate injection from $3. 93 to $198。
Other examples, such as broad-spectrum antibiotic glycol ointment, increased from $1. 07 to $47. 3; and amino-helicoplasmic injection from 0. 66 in 2011 to $51. 04. The price of hbcp injection fluid increased from $0. 23 to $56. 8 in 2017. Injection of the narcotic drug bubikaine has increased from a minimum price of $0. 7 in 2013 to $ 36. 48 in 2019。
Anti-shock drugs have increased from a few corners to more than 20 per cent of sodium phenylbarbitor injections of heavy glycerine to adrenaline, nitric glycerin injections, fur serme injections and injections of epilepsy. In contrast, the same as anaesthetic acid lydocaine injection fluids rose slightly, from 0. 31 to 9. 62 (2021)。
The interface news-writing revealed that the price increases for each drug were roughly proportional to the number of batch numbers. For example, the relatively small increase in the first aid drug, lidocara hydrochloride, has 214 relevant batch numbers for injection fluids, while the larger increase in westland and disemyson has only 3 batch numbers. The most exaggerated price increase for acetic anhydride, the semyson injection fluid, is currently the only batch number obtained by chengdu topsun pharmaceuticals ltd., which is the sole-sourced agent of the company。
However, the price of their drugs has not been uniform in the provinces and municipalities. For example, the maximum price of the disemisone (1ml; 5mg) could reach 230 yuan/salary, but in july last year in shanxi, an offer was made to reduce the price by 98. 76 per cent (the same agent type)。
The price of the diocesin award in different provinces
Even at this price, however, there is a considerable burden on public hospitals and patients。
A representative of the national people's congress, secretary of the party of first people's hospital of changzhou city. In a press interview, it was stated that “the price increase alone would increase the patient's burden by $1. 424 million per year, calculated on the basis of the number of people's first people's hospital in the city of chuzhou in 2021”。
In fact, the increase in the price of first aid drugs is not new, but rather “recalcitrant”。
According to a paper published in chinese medicines by ho kang ling, the medical waste management centre of the city of hanhu, anhui province, a central hospital in anhui province, for the period 2015-2019, the price of 80 per cent of the medicines increased to the national essential drugs, essentially emergency and basic drugs。
Many papers mention that the rise in the price of medicines depends on changes in our drug price policy. Our policy of low-cost drugs (no more than $3 for western drugs and no more than $5 for chinese medicines) has a transition from government to market。
According to the lilac insight data, most of the price increases for medicines are concentrated after 2015. In may of that year, the national commission for development and development had issued a reform of the price of medicines to eliminate drug prices set by the previous government, with the exception of narcotic drugs and type i psychotropic substances. This also means that medicines enter market-led pricing patterns。
In order to protect the rights and interests of patients, the state has generally adopted a low-cost model for life-saving drugs, etc. Also in 2015, the state published a list of low-priced medicines within the price range, which included the dozens of emergency medicines mentioned above。
However, long-term low prices undermine the incentives for medicine. Operating costs have risen, production enterprises have been unable to supply; the “two-vote” system has increased the bargaining power of raw-material pharmacies, and there has been a shortage of medicines and a shortage of supplies. Unpricing could lead to higher prices for the corresponding drugs, even as a clinical emergency. Data on the purchase of low-priced medicines for three years at a hospital such as liu saemoto indicate that the price of low-priced drugs rose significantly after shaanxi liberalized its maximum price。
In october 2019, the office of the state council published its opinions on improving the safeguarding of shortfalled medicines to secure prices, including measures to strengthen early warning of price anomalies of medicines and to manage the list of shortages。
In the course of the two sessions this year, the rise in the price of medicines to contain the shortage was again reflected in the proposals of the high representative. On behalf of rentong, the congress noted that a number of pharmaceutical companies were increasing prices. She suggested that policies should be put in place to regularize the price of medicines and secure short-term medicines。
These include, first, strict control of pricing and approval of price increases for the same drug variant. Second, the centralized charge of medicines in the health insurance catalogue is procured, and the health insurance payment criteria are established on the basis of the selected price. Third, the same health insurance payment standard is applied to generic drugs, reference formulations and generic drugs evaluated through consistency. Fourth, for generic drugs that are not evaluated through consistency, the standard of payment for health insurance must not be higher than those that have been evaluated through consistency under the same generic name。
